Laura Estela Castrillón Rivera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Laura Estela Castrillón Rivera has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Alejandro Palma-Ramos
Departamento de Sistemas Biológicos, Universidad Autónoma Metropolitana Unidad Xochimilco, Mexico City 04960, Mexico
4 shared publications - Jorge Ismael Castañeda-Sánchez
Departamento de Sistemas Biológicos, Universidad Autónoma Metropolitana, Unidad Xochimilco, Mexico City 04960, Mexico
4 shared publications Alejandro Palma Ramos
Laboratorio de Inmunología, Departamento de Sistemas Biológicos, Universidad Autónoma Metropolitana Unidad Xochimilco, México
2 shared publications- Felipe Mendoza-Pérez
Laboratorio de Biotecnologia, Departamento de Sistemas Biológicos, Universidad Autonoma Metropolitana Unidad Xochimilco, Calzada del Hueso 1100, Colonia Villa Quietud, Ciudad de México 04960, Mexico
2 shared publications Jorge Ismael Castañeda Sánchez
Laboratorio de Inmunología, Departamento de Sistemas Biológicos, Universidad Autónoma Metropolitana Unidad Xochimilco, México
2 shared publications- Julieta Luna-Herrera
Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México 11340, Mexico
2 shared publications
Latest Publications
- Open Access
- 6 June 2024
- Published by Universidad Nacional de Colombia in Revista Colombiana de Ciencias Químico Farmacéuticas
- Vol. 53 (2) , 537-555
Nanoparticles: A delivery system for antifungals
Introduction: The increase in the incidence of pathologies in which fungi appear as emerging pathogens is mainly associated with opportunistic fungi as well as susceptibility in patients with a certain degree of immunodeficiency because they present some risk factors such as neutropenia, diabetes, surgeries, abuse of antibiotic treatment, nosocomial diseases and transplant patients among others. To date, antifungal therapy is far from being ideal because in addition to resistance to antifungals, there is a limitation of their availability as a consequence of their toxicity, as well as the decrease in the effectiveness of the drug in free form, minimal restricted penetration. to tissues, decreased bioavailability, poor pharmacokinetics, lack of selectivity, severe side effects and low water solubility: Due to this situation, it is necessary to have new therapeutic measures that are efficient to combat mainly invasive mycoses, hence the objective of this review work to know the state of the art of the various antifungal delivery systems. Development of the topic: This bibliographic review addresses the following aspects related to: a) Types and structure of nanomaterials, b) Antifungal activity of nanoparticles and c) In vivo evaluation and cytotoxicity of nanoparticles. Conclusion: The development of new technologies and synthesis of nanomaterials emerges as a possible alternative for the treatment of fungal infections. In this work, the main advances related to nanomaterials designed as a possible delivery system for antifungals are presented.
- 6 June 2024
- Published by Universidad Nacional de Colombia in Revista Colombiana de Ciencias Químico Farmacéuticas
- Vol. 53 (2) , 537-555
Open AccessNanoparticles: A delivery system for antifungals
Introduction: The increase in the incidence of pathologies in which fungi appear as emerging pathogens is mainly associated with opportunistic fungi as well as susceptibility in patients with a certain degree of immunodeficiency because they present some risk factors such as neutropenia, diabetes, surgeries, abuse of antibiotic treatment, nosocomial diseases and transplant patients among others. To date, antifungal therapy is far from being ideal because in addition to resistance to antifungals, there is a limitation of their availability as a consequence of their toxicity, as well as the decrease in the effectiveness of the drug in free form, minimal restricted penetration. to tissues, decreased bioavailability, poor pharmacokinetics, lack of selectivity, severe side effects and low water solubility: Due to this situation, it is necessary to have new therapeutic measures that are efficient to combat mainly invasive mycoses, hence the objective of this review work to know the state of the art of the various antifungal delivery systems. Development of the topic: This bibliographic review addresses the following aspects related to: a) Types and structure of nanomaterials, b) Antifungal activity of nanoparticles and c) In vivo evaluation and cytotoxicity of nanoparticles. Conclusion: The development of new technologies and synthesis of nanomaterials emerges as a possible alternative for the treatment of fungal infections. In this work, the main advances related to nanomaterials designed as a possible delivery system for antifungals are presented.
- Open Access
- 6 April 2024
- Published by Universidad Nacional de Colombia in Revista Colombiana de Ciencias Químico Farmacéuticas
- Vol. 53 (1)
El uso de anticuerpos monoclonales en dermatología
Introducción: La participación de los componentes inmunitarios en las patologías inflamatorias de la piel ha traído como consecuencia la posibilidad de intervenir en los procesos que las desencadenan o perpetúan, de ahí la importancia de conocer las diversas terapias biológicas que tienen como blanco, proteínas específicas que son el resultado de la disfunción de la respuesta inmune en varias enfermedades de la piel. En el presente trabajo de revisión, se presentan diversos aspectos relacionados con el criterio de selección de los productos biológicos (o biofarmacéuticos) con particular interés en los anticuerpos monoclonales (mAb) así como las principales patologías dermatológicas en los que se han aplicado. Esto, en virtud de que los mAb se han utilizado mayormente en la terapéutica de neoplasias y se explora la posibilidad de su uso en otros padecimientos de la piel además del cáncer. Desarrollo del tema: La presente revisión bibliográfica aborda los principales aspectos relacionados con: a) Seguridad e inmunogenicidad de los anticuerpos monoclonales, b) Aplicaciones terapéuticas de los mAb en dermatología: Psoriasis, Dermatitis atópica, Hidrandenigtis supurativa, Urticaria, Pénfigo, Alopecia areata, Pioderma gangrenoso Pitiriasis nubra pilaris, Sarcoidosis cutánea, Síndrome de Behcet y en otras patologías, c) Biosimilares en dermatología y d) Lesiones cutáneas asociadas con el uso de anticuerpos monoclonales. Discusión: La terapéutica basada en mAb es un área de constante crecimiento y la tecnología recombinante ha permitido la obtención de moléculas cada vez más estables y menos inmunogénicas que permitirán ofrecer opciones terapéuticas a varias patologías dermatológicas con características de hiperinflamación o inmunosupresión. Conclusión: El aumento de estudios clínicos para el uso potencial de anticuerpos monoclonales en dermatología permitirán su autorización por las agencias regulatorias y aumentar el arsenal terapéutico para padecimientos de difícil control.
- 6 April 2024
- Published by Universidad Nacional de Colombia in Revista Colombiana de Ciencias Químico Farmacéuticas
- Vol. 53 (1)
Open AccessEl uso de anticuerpos monoclonales en dermatología
Introducción: La participación de los componentes inmunitarios en las patologías inflamatorias de la piel ha traído como consecuencia la posibilidad de intervenir en los procesos que las desencadenan o perpetúan, de ahí la importancia de conocer las diversas terapias biológicas que tienen como blanco, proteínas específicas que son el resultado de la disfunción de la respuesta inmune en varias enfermedades de la piel. En el presente trabajo de revisión, se presentan diversos aspectos relacionados con el criterio de selección de los productos biológicos (o biofarmacéuticos) con particular interés en los anticuerpos monoclonales (mAb) así como las principales patologías dermatológicas en los que se han aplicado. Esto, en virtud de que los mAb se han utilizado mayormente en la terapéutica de neoplasias y se explora la posibilidad de su uso en otros padecimientos de la piel además del cáncer. Desarrollo del tema: La presente revisión bibliográfica aborda los principales aspectos relacionados con: a) Seguridad e inmunogenicidad de los anticuerpos monoclonales, b) Aplicaciones terapéuticas de los mAb en dermatología: Psoriasis, Dermatitis atópica, Hidrandenigtis supurativa, Urticaria, Pénfigo, Alopecia areata, Pioderma gangrenoso Pitiriasis nubra pilaris, Sarcoidosis cutánea, Síndrome de Behcet y en otras patologías, c) Biosimilares en dermatología y d) Lesiones cutáneas asociadas con el uso de anticuerpos monoclonales. Discusión: La terapéutica basada en mAb es un área de constante crecimiento y la tecnología recombinante ha permitido la obtención de moléculas cada vez más estables y menos inmunogénicas que permitirán ofrecer opciones terapéuticas a varias patologías dermatológicas con características de hiperinflamación o inmunosupresión. Conclusión: El aumento de estudios clínicos para el uso potencial de anticuerpos monoclonales en dermatología permitirán su autorización por las agencias regulatorias y aumentar el arsenal terapéutico para padecimientos de difícil control.
- Open Access
- 23 April 2022
- Published by MDPI AG in Journal of Fungi
- Vol. 8 (5) , 437
Keratinocyte Response to Infection with Sporothrix schenckii
Sporotrichosis is a subacute, or chronic mycosis caused by traumatic inoculation of material contaminated with the fungus Sporothrix schenckii which is part of the Sporothrix spp. complex. The infection is limited to the skin, although its progression to more severe systemic or disseminated forms remains possible. Skin is the tissue that comes into contact with Sporothrix first, and the role of various cell lines has been described with regard to infection control. However, there is little information on the response of keratinocytes. In this study, we used the human keratinocyte cell line (HaCaT) and evaluated different aspects of infection from modifications in the cytoskeleton to the expression of molecules of the innate response during infection with conidia and yeast cells of Sporothrix schenckii. We found that during infection with both phases of the fungus, alterations of the actin cytoskeleton, formation of membrane protuberances, and loss of stress fibers were induced. We also observed an overexpression of the surface receptors MR, TLR6, CR3 and TLR2. Cytokine analysis showed that both phases of the fungus induced the production of elevated levels of the chemokines MCP-1 and IL-8, and proinflammatory cytokines IFN-, IFN- and IL-6. In contrast, TNF- production was significant only with conidial infection. In late post-infection, cytokine production was observed with immunoregulatory activity, IL-10, and growth factors, G-CSF and GM-CSF. In conclusion, infection of keratinocytes with conidia and yeast cells of Sporothrix schenckii induces an inflammatory response and rearrangements of the cytoskeleton.- 23 April 2022
- Published by MDPI AG in Journal of Fungi
- Vol. 8 (5) , 437
Open AccessKeratinocyte Response to Infection with Sporothrix schenckii
Sporotrichosis is a subacute, or chronic mycosis caused by traumatic inoculation of material contaminated with the fungus Sporothrix schenckii which is part of the Sporothrix spp. complex. The infection is limited to the skin, although its progression to more severe systemic or disseminated forms remains possible. Skin is the tissue that comes into contact with Sporothrix first, and the role of various cell lines has been described with regard to infection control. However, there is little information on the response of keratinocytes. In this study, we used the human keratinocyte cell line (HaCaT) and evaluated different aspects of infection from modifications in the cytoskeleton to the expression of molecules of the innate response during infection with conidia and yeast cells of Sporothrix schenckii. We found that during infection with both phases of the fungus, alterations of the actin cytoskeleton, formation of membrane protuberances, and loss of stress fibers were induced. We also observed an overexpression of the surface receptors MR, TLR6, CR3 and TLR2. Cytokine analysis showed that both phases of the fungus induced the production of elevated levels of the chemokines MCP-1 and IL-8, and proinflammatory cytokines IFN-, IFN- and IL-6. In contrast, TNF- production was significant only with conidial infection. In late post-infection, cytokine production was observed with immunoregulatory activity, IL-10, and growth factors, G-CSF and GM-CSF. In conclusion, infection of keratinocytes with conidia and yeast cells of Sporothrix schenckii induces an inflammatory response and rearrangements of the cytoskeleton. - Open Access
- 25 September 2021
- Published by MDPI AG in Microorganisms
- Vol. 9 (10) , 2027
Bacillus licheniformis and Bacillus subtilis, Probiotics That Induce the Formation of Macrophage Extracellular Traps
Probiotics are considered living microorganisms that help preserve the health of the host who uses them. Bacillus are a genus of Gram-positive bacteria used as probiotics for animal and human consumption. They are currently distributed in various commercial forms. Two of the species used as probiotics are B. licheniformis and B. subtilis. Macrophages are central cells in the immune response, being fundamental in the elimination of microbial pathogens, for which they use various mechanisms, including the formation of extracellular traps (METs). There have been very few studies carried out on the participation of macrophages in response to the interaction of probiotics of the genus Bacillus with the host. In this work, we used macrophages from the J774A mouse cell line.1, and we found that they are susceptible to infection by the two Bacillus species. However, both species were eliminated as the infection progressed. Using confocal microscopy, we identified the formation of METs from the first hours of infection, which were characterized by the presence of myeloperoxidase (MPO) and citrullinated histone (Hit3Cit). Quantitative data on extracellular DNA release were also obtained; release was observed starting in the first hour of infection. The induction of METs by B. licheniformis caused a significant decrease in the colony-forming units (CFU) of Staphylococcus aureus. The induction of METS by bacteria of the Bacillus genus is a mechanism that participates in controlling the probiotic and potentially pathogenic bacteria such as S. aureus. The induction of METs to control pathogens may be a novel mechanism that could explain the beneficial effects of probiotics of the genus Bacillus.
- 25 September 2021
- Published by MDPI AG in Microorganisms
- Vol. 9 (10) , 2027
Open AccessBacillus licheniformis and Bacillus subtilis, Probiotics That Induce the Formation of Macrophage Extracellular Traps
Probiotics are considered living microorganisms that help preserve the health of the host who uses them. Bacillus are a genus of Gram-positive bacteria used as probiotics for animal and human consumption. They are currently distributed in various commercial forms. Two of the species used as probiotics are B. licheniformis and B. subtilis. Macrophages are central cells in the immune response, being fundamental in the elimination of microbial pathogens, for which they use various mechanisms, including the formation of extracellular traps (METs). There have been very few studies carried out on the participation of macrophages in response to the interaction of probiotics of the genus Bacillus with the host. In this work, we used macrophages from the J774A mouse cell line.1, and we found that they are susceptible to infection by the two Bacillus species. However, both species were eliminated as the infection progressed. Using confocal microscopy, we identified the formation of METs from the first hours of infection, which were characterized by the presence of myeloperoxidase (MPO) and citrullinated histone (Hit3Cit). Quantitative data on extracellular DNA release were also obtained; release was observed starting in the first hour of infection. The induction of METs by B. licheniformis caused a significant decrease in the colony-forming units (CFU) of Staphylococcus aureus. The induction of METS by bacteria of the Bacillus genus is a mechanism that participates in controlling the probiotic and potentially pathogenic bacteria such as S. aureus. The induction of METs to control pathogens may be a novel mechanism that could explain the beneficial effects of probiotics of the genus Bacillus.
- 19 May 2019
- Published by Springer Nature in Folia Microbiologica
- Vol. 65 (1) , 133-142
Analysis of inflammatory cytokine expression in the urinary tract of BALB/c mice infected with Proteus (P.) mirabilis and enteroaggregative Escherichia (E.) coli (EAEC) strains
This study aimed to analyze the proinflammatory cytokine mRNA expression in the urinary tract of BALB/c mice infected with bacterial strains with uropathogenic potential. Groups of four 6-week-old female BALB/c mice were intraurethrally inoculated with 5 × 107 colony-forming units (CFU) of P. mirabilis ATCC29906, EAEC O42, P. mirabilis RTX339, or sterile saline (control group) and then sacrificed at 0, 2, 4, 7, or 10 days post-infection (p.i.). Samples were cultured to determine the CFU/mL in urine or CFU/g in the bladders and kidneys. Cytokine expression (tumor necrosis factor (TNF)-α and interleukin (IL)-1β, -6, and -8) was evaluated in the target organs using real-time PCR and immunohistochemistry; histology was examined with hematoxylin and eosin staining. The results are presented as the means and standard deviations and were compared using one-way ANOVA, with p < 0.05 indicating significant differences. Bacteriuria was not detected in the infected groups; bacterial colonization occurred in the target organs at all time points, but was higher in mice infected with EAEC O42 or P. mirabilis RTX339 at 7 days p.i. The expression of all cytokine mRNAs was seen, but only the levels of the IL-8 protein increased in situ at 7 days p.i. in the P. mirabilis RTX339 and EAEC O42 groups in both organs. Morphological alterations, observed in all of the infected groups, were more prominent in the EAEC O42 and P. mirabilis RTX339 groups. The findings provide insights into the uropathogenicity and inflammatory cytokine expression in the urinary tract of mice infected with three previously untested bacterial strains.
- 19 May 2019
- Published by Springer Nature in Folia Microbiologica
- Vol. 65 (1) , 133-142
Analysis of inflammatory cytokine expression in the urinary tract of BALB/c mice infected with Proteus (P.) mirabilis and enteroaggregative Escherichia (E.) coli (EAEC) strains
This study aimed to analyze the proinflammatory cytokine mRNA expression in the urinary tract of BALB/c mice infected with bacterial strains with uropathogenic potential. Groups of four 6-week-old female BALB/c mice were intraurethrally inoculated with 5 × 107 colony-forming units (CFU) of P. mirabilis ATCC29906, EAEC O42, P. mirabilis RTX339, or sterile saline (control group) and then sacrificed at 0, 2, 4, 7, or 10 days post-infection (p.i.). Samples were cultured to determine the CFU/mL in urine or CFU/g in the bladders and kidneys. Cytokine expression (tumor necrosis factor (TNF)-α and interleukin (IL)-1β, -6, and -8) was evaluated in the target organs using real-time PCR and immunohistochemistry; histology was examined with hematoxylin and eosin staining. The results are presented as the means and standard deviations and were compared using one-way ANOVA, with p < 0.05 indicating significant differences. Bacteriuria was not detected in the infected groups; bacterial colonization occurred in the target organs at all time points, but was higher in mice infected with EAEC O42 or P. mirabilis RTX339 at 7 days p.i. The expression of all cytokine mRNAs was seen, but only the levels of the IL-8 protein increased in situ at 7 days p.i. in the P. mirabilis RTX339 and EAEC O42 groups in both organs. Morphological alterations, observed in all of the infected groups, were more prominent in the EAEC O42 and P. mirabilis RTX339 groups. The findings provide insights into the uropathogenicity and inflammatory cytokine expression in the urinary tract of mice infected with three previously untested bacterial strains.
- Open Access
- 3 April 2019
- Published by IntechOpen
Origin and Control Strategies of Biofilms in the Cultural Heritage
Biodeterioration is defined as the undesirable change in the properties of materials caused by the activity of biological agents. This process is complex and involves alterations in the physicochemical and mechanical properties by the action of organisms and depends on the microorganisms involved, type of substrate, and environmental conditions. The biodeterioration of cultural heritage is the physical or chemical damage caused by microorganisms on objects, monuments, or buildings that belong to the cultural heritage. Among the main materials that can be affected are: stone, metal, ceramic, polymers, and other materials. Among the main undesirable effects to these materials are: discoloration, dissolution, rupture, and efflorescence among others. Biofilms represent the usual form of growth of bacteria and consist of communities of microorganisms that grow attached to an inert surface or a living tissue, surrounded by an extracellular matrix that they themselves synthesize. The importance of biodeterioration by biofilms is mainly related to changes in pH values, ionic concentrations, oxide-reduction reactions in the biofilm thickness, and in the interface with the substrate and enzymatic degradation. This chapter presents evidence of the participation of biofilms and associated mechanisms in biodeterioration as well as the main prevention and control strategies.
- 3 April 2019
- Published by IntechOpen
Open AccessOrigin and Control Strategies of Biofilms in the Cultural Heritage
Biodeterioration is defined as the undesirable change in the properties of materials caused by the activity of biological agents. This process is complex and involves alterations in the physicochemical and mechanical properties by the action of organisms and depends on the microorganisms involved, type of substrate, and environmental conditions. The biodeterioration of cultural heritage is the physical or chemical damage caused by microorganisms on objects, monuments, or buildings that belong to the cultural heritage. Among the main materials that can be affected are: stone, metal, ceramic, polymers, and other materials. Among the main undesirable effects to these materials are: discoloration, dissolution, rupture, and efflorescence among others. Biofilms represent the usual form of growth of bacteria and consist of communities of microorganisms that grow attached to an inert surface or a living tissue, surrounded by an extracellular matrix that they themselves synthesize. The importance of biodeterioration by biofilms is mainly related to changes in pH values, ionic concentrations, oxide-reduction reactions in the biofilm thickness, and in the interface with the substrate and enzymatic degradation. This chapter presents evidence of the participation of biofilms and associated mechanisms in biodeterioration as well as the main prevention and control strategies.